Literature DB >> 8832719

New insights into the pathogenesis of choroideremia: a tale of two REPs.

M C Seabra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8832719     DOI： 10.3109/13816819609057869

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN： 1381-6810            Impact factor:   1.803


× No keyword cloud information.
  16 in total

1.  Topical dorzolamide for treatment of cystoid macular edema in patients with choroideremia.

Authors:  Mohamed A Genead; Jason J McAnany; Gerald A Fishman
Journal:  Retina       Date:  2012-04       Impact factor: 4.256

Review 2.  A comprehensive review of retinal gene therapy.

Authors:  Shannon E Boye; Sanford L Boye; Alfred S Lewin; William W Hauswirth
Journal:  Mol Ther       Date:  2013-01-29       Impact factor: 11.454

3.  Polyisoprenylation potentiates the inhibition of polyisoprenylated methylated protein methyl esterase and the cell degenerative effects of sulfonyl fluorides.

Authors:  Byron Aguilar; Felix Amissah; Randolph Duverna; Nazarius S Lamango
Journal:  Curr Cancer Drug Targets       Date:  2011-07       Impact factor: 3.428

4.  The role of Rab27a in the regulation of melanosome distribution within retinal pigment epithelial cells.

Authors:  Clare E Futter; José S Ramalho; Gesine B Jaissle; Mathias W Seeliger; Miguel C Seabra
Journal:  Mol Biol Cell       Date:  2004-02-20       Impact factor: 4.138

5.  Noncell-autonomous photoreceptor degeneration in a zebrafish model of choroideremia.

Authors:  Bryan L Krock; Joseph Bilotta; Brian D Perkins
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

6.  Independent degeneration of photoreceptors and retinal pigment epithelium in conditional knockout mouse models of choroideremia.

Authors:  Tanya Tolmachova; Ross Anders; Magnus Abrink; Laurence Bugeon; Margaret J Dallman; Clare E Futter; José S Ramalho; Felix Tonagel; Naoyuki Tanimoto; Mathias W Seeliger; Clare Huxley; Miguel C Seabra
Journal:  J Clin Invest       Date:  2006-01-12       Impact factor: 14.808

Review 7.  Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities.

Authors:  J O Agola; P A Jim; H H Ward; S Basuray; A Wandinger-Ness
Journal:  Clin Genet       Date:  2011-07-13       Impact factor: 4.438

8.  Rab proteins and the secretory pathway: the case of rab18 in neuroendocrine cells.

Authors:  Rafael Vázquez-Martínez; Maria M Malagón
Journal:  Front Endocrinol (Lausanne)       Date:  2011-01-17       Impact factor: 5.555

9.  Rapid degradation of dominant-negative Rab27 proteins in vivo precludes their use in transgenic mouse models.

Authors:  José S Ramalho; Ross Anders; Gesine B Jaissle; Mathias W Seeliger; Clare Huxley; Miguel C Seabra
Journal:  BMC Cell Biol       Date:  2002-10-28       Impact factor: 4.241

10.  AAV-mediated gene therapy for choroideremia: preclinical studies in personalized models.

Authors:  Vidyullatha Vasireddy; Jason A Mills; Rajashekhar Gaddameedi; Etiena Basner-Tschakarjan; Monika Kohnke; Aaron D Black; Krill Alexandrov; Shangzhen Zhou; Albert M Maguire; Daniel C Chung; Helen Mac; Lisa Sullivan; Paul Gadue; Jeannette L Bennicelli; Deborah L French; Jean Bennett
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.